JCN Newswire Read More Biogen Announces Reduced Price for Aduhelm to Improve Access For Patients With Early Alzheimer’s Disease In The United States ruth 21 12 月 5 minutes TOKYO, Dec 21, 2021 – (J […]
JCN Newswire Read More Eisai: New Phase 3 Data Show Positive Correlation Between ADUHELM Treatment Effect on Biomarkers and Reduction in Clinical Decline in Alzheimer’s Disease ruth 12 11 月 4 minutes TOKYO, Nov 12, 2021 – (J […]
JCN Newswire Read More FDA grants accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease ruth 8 6 月 4 minutes TOKYO, Jun 8, 2021 – (JC […]
